• News
    • Press Releases
  • Media Kit
  • Media Resources
    • Images
    • Video
  • Media Contacts
  • Corporate Site

Impulse Dynamics Announces 7000th Patient Treated With CCM Reinforcing Significant Clinical Experience

by Impulse Dynamics | Apr 26, 2022 | News and Events, Press Releases

CCM Therapy Addresses an Unmet Clinical Need and Offers Hope to Millions With Heart Failure MARLTON, N.J., April 26, 2022 (GLOBE NEWSWIRE) — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), is proud...

Impulse Dynamics’ Quality Management System Receives Certification Under European Union Medical Device Regulation

by Impulse Dynamics | Mar 22, 2022 | News and Events, Press Releases

Impulse Dynamics Is Now Among the First US-based Manufacturers of Active Implantable Devices To Receive Certification MARLTON, N.J., March 22, 2022 (GLOBE NEWSWIRE) — Impulse Dynamics, a company dedicated to innovative treatments for chronic heart failure, is pleased...

Impulse Dynamics’ Quality Management System Receives Certification Under European Union Medical Device Regulation

by Impulse Dynamics | Mar 22, 2022 | News and Events, Press Releases

Impulse Dynamics Is Now Among the First US-based Manufacturers of Active Implantable Devices To Receive Certification MARLTON, N.J., March 22, 2022 (GLOBE NEWSWIRE) — Impulse Dynamics, a company dedicated to innovative treatments for chronic heart failure, is pleased...

Impulse Dynamics Announces First Patient Enrolled in AIM HIGHer — Implantable Device Trial to Treat Heart Failure in Higher EF Population

by Impulse Dynamics | Mar 14, 2022 | News and Events, Press Releases

Trial Evaluates FDA-Designated Breakthrough Therapy for Patients Who Lack Treatment Options MARLTON, N.J., March 14, 2022 — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), today announced that the...

Impulse Dynamics Announces Chief Financial Officer Transition

by Impulse Dynamics | Jan 25, 2022 | News and Events, Press Releases

Harriss Currie to Succeed Gerry Haines MARLTON, N.J., January 25, 2022 — Impulse Dynamics N.V., a company dedicated to improving the lives of people with heart failure, today announced the appointment of Harriss T. Currie as Executive Vice President and Chief...
« Older Entries
Next Entries »

Clinical Trial Corporate Investors

  • Follow
  • Follow
  • Follow
  • Follow

We welcome the opportunity to hear from you in these social channels, but remember we work in a highly-regulated industry with unique legal considerations. Before engaging, please read and adhere to our established community guidelines for each channel.

The information posted on this site was factually accurate on the date of publication.

© Impulse Dynamics 2024   Privacy Policy